Retraining and Control Therapy ReACT for Pediatric Psychogenic Non-Epileptic Seizures Targeting Sense of Control and Symptom Expectations in Children and Teens
Led by University of Alabama at Birmingham · Updated on 2026-08-26
68
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating Retraining and Control Therapy ReACT, a cognitive behavioral treatment aimed at improving sense of control and reducing catastrophic symptom expectations in children and teenagers aged 11 to 18 diagnosed with pediatric psychogenic non-epileptic seizures PNES. These seizures resemble epileptic seizures but lack a medical cause. The study focuses on understanding these psychological targets to improve therapy outcomes for PNES.
Participants will complete twelve weekly ReACT therapy sessions, with the initial visit lasting up to two hours and the following sessions lasting about one hour each. During the study, participants will undergo the cold pressor test CPT twice at baseline, with randomization to a pain relief or pain sensitivity lotion applied during the second test. After finishing the 12 sessions, half of the participants will receive two booster therapy sessions at 3 and 9 months post-treatment. Healthy controls matched by age, gender, race, and family income will have baseline and follow-up visits similar to those with PNES.
Throughout the study, participants and their parents will complete questionnaires assessing mood, symptoms, and quality of life. PNES frequency will be tracked using diaries from 30 days before treatment to 12 months after. Assessments include tasks measuring sense of control, pain tolerance, cortisol response, and cognitive tests at baseline, mid-treatment, post-treatment, and long-term follow-ups at 6 and 12 months via secure video calls. Participants will wear Actiwatch devices to monitor sleep and seizure severity during specific periods. Saliva samples will be collected to measure stress hormone responses during CPT visits.
CONDITIONS
Brief Title
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
Research Team
A
Aaron Fobian, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
ReACT + Booster sessions
ReACT without Booster sessions
Healthy Control (no intervention)
What it is
Behavioral therapy (ReACT) delivered with additional booster sessions targeting control and symptom expectations
Behavioral therapy (ReACT) without booster sessions targeting sense of control and symptom expectations
Healthy control group with no behavioral intervention
Primary study purpose
To assess whether ReACT with booster sessions improves control and symptom expectations in pediatric PNES
To evaluate ReACT therapy alone for improving sense of control and symptom expectations in pediatric PNES
To compare baseline level of control and symptom expectations without intervention
Administration / execution
Participants receive ReACT behavioral sessions followed by additional booster therapy sessions
Participants receive ReACT behavioral treatment without booster sessions
No intervention or therapy is delivered
Broader clinical context or evidence status
Investigational behavioral therapy for pediatric functional seizures; no published results yet
Investigational behavioral therapy for pediatric functional seizures; not yet established in clinical practice
No active treatment; not representative of clinical care for PNES
Key limitations
Behavioral interventions may vary in adherence and response among pediatric PNES patients
Without booster sessions, treatment effects may decline over time without reinforcement
Healthy control does not reflect typical clinical management for PNES, limiting generalizability
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 11Years - 18Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Age between 9 and 18 years
Diagnosis of psychogenic non-epileptic seizures confirmed by video-EEG
A family member, such as a parent, willing to participate alongside the participant
You will not qualify if you...
Diagnosis of epilepsy
Fewer than 4 psychogenic non-epileptic seizures per month
Other paroxysmal nonepileptic events like hypoxic-ischemic episodes, sleep disorders, or migraine-associated disorders
Participation in other therapy during the study
Severe intellectual disability
Severe mental illness involving delusions or hallucinations
Blood pressure over 130/80 mmHg for adolescents aged 13 years or older
Blood pressure at or above the 95th percentile for sex and age in children under 13 years
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 baseline laboratory visit lasting about 3 hours
Treatment
Duration - 12 weeks
Participants complete twelve weekly therapy sessions of Retraining and Control Therapy (ReACT). Initial session includes cognitive tests and cold pressor tests with randomized lotion application. Sessions 2 to 12 are about one hour each, mostly conducted via telehealth. Saliva samples and sleep monitoring occur during treatment.
12 weekly sessions plus 2 post-treatment lab visits after the 8th and 12th sessions
Booster Therapy (for some participants)
Duration - 6 months
Half of the participants receive two booster therapy sessions at 3 and 9 months after completing the 12 main sessions to reinforce treatment effects.
2 booster sessions, one at 3 months and one at 9 months post-treatment
Long-term Follow-up
Duration - 12 months
Participants complete questionnaires and assessments at 6 and 12 months after treatment via secure video calls to monitor seizure frequency and psychological outcomes.
2 follow-up visits via HIPAA-compliant Zoom at 6 and 12 months post-treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Similar Trials
Feasibility Study Comparing Two Therapies for Functional Seizures in Children and Teens Aged 11 to 18
Developing a Team-Based Treatment Program for Functional Neurological Disorder FND at University of Alabama at Birmingham
Cognitive Behavioral Therapy Study for Youth with Psychogenic Non-Epileptic Seizures PNES Using Retraining and Control Therapy ReACT
Retraining and Control Therapy ReACT for Adults with Psychogenic Non-Epileptic Seizures PNES to Improve Sense of Control and Reduce Symptom Expectations
Retraining and Control Therapy ReACT for Pediatric Psychogenic Non-Epileptic Seizures Targeting Sense of Control and Symptom Expectations in Children and Teens
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Retraining and control therapy: sense of control and catastrophic symptom expectations as targets of a cognitive behavioral treatment for pediatric functional seizures.
Caroline Watson, Badhma Valaiyapathi, Jerzy P Szaflarski...